DK0971714T3 - Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens - Google Patents
Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demensInfo
- Publication number
- DK0971714T3 DK0971714T3 DK98912108T DK98912108T DK0971714T3 DK 0971714 T3 DK0971714 T3 DK 0971714T3 DK 98912108 T DK98912108 T DK 98912108T DK 98912108 T DK98912108 T DK 98912108T DK 0971714 T3 DK0971714 T3 DK 0971714T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclooxygenase
- inhibitors
- dementia
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4391697P | 1997-04-03 | 1997-04-03 | |
PCT/US1998/006143 WO1998043648A1 (en) | 1997-04-03 | 1998-03-30 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0971714T3 true DK0971714T3 (da) | 2002-11-04 |
Family
ID=21929578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98912108T DK0971714T3 (da) | 1997-04-03 | 1998-03-30 | Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0971714B1 (da) |
JP (1) | JP2002514208A (da) |
AT (1) | ATE225660T1 (da) |
AU (1) | AU725697B2 (da) |
BR (1) | BR9807920A (da) |
CA (1) | CA2285434A1 (da) |
DE (1) | DE69808607T2 (da) |
DK (1) | DK0971714T3 (da) |
ES (1) | ES2185154T3 (da) |
HK (1) | HK1024872A1 (da) |
PT (1) | PT971714E (da) |
WO (1) | WO1998043648A1 (da) |
ZA (1) | ZA982808B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9420616D0 (en) * | 1994-10-12 | 1994-11-30 | Merck Sharp & Dohme | Method, compositions and use |
ATE212985T1 (de) * | 1993-11-30 | 2002-02-15 | Searle & Co | Tricyclische,substituierte pyrazolyl- benzolsulfonamide und ihre verwendung als cyclooxygenase ii inhibitoren |
US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
US5696143A (en) * | 1994-09-20 | 1997-12-09 | Talley; John J. | Benz G! indazolyl derivatives for the treatment of inflammation |
EP0828718A1 (en) * | 1995-06-02 | 1998-03-18 | G.D. SEARLE & CO. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
US6342510B1 (en) * | 1995-06-12 | 2002-01-29 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist |
WO1996041626A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
TR199802049T2 (xx) * | 1996-04-12 | 1999-01-18 | G.D.Searle & Co. | COX-2 Inhibit�rlerinin �nilac� olarak s�bstit�e edilmi� benzens�lfonamid t�revleri. |
-
1998
- 1998-03-30 DK DK98912108T patent/DK0971714T3/da active
- 1998-03-30 AU AU65904/98A patent/AU725697B2/en not_active Ceased
- 1998-03-30 DE DE69808607T patent/DE69808607T2/de not_active Expired - Fee Related
- 1998-03-30 AT AT98912108T patent/ATE225660T1/de not_active IP Right Cessation
- 1998-03-30 BR BR9807920-4A patent/BR9807920A/pt not_active IP Right Cessation
- 1998-03-30 EP EP98912108A patent/EP0971714B1/en not_active Expired - Lifetime
- 1998-03-30 PT PT98912108T patent/PT971714E/pt unknown
- 1998-03-30 WO PCT/US1998/006143 patent/WO1998043648A1/en active IP Right Grant
- 1998-03-30 CA CA002285434A patent/CA2285434A1/en not_active Abandoned
- 1998-03-30 JP JP54186898A patent/JP2002514208A/ja not_active Ceased
- 1998-03-30 ES ES98912108T patent/ES2185154T3/es not_active Expired - Lifetime
- 1998-04-02 ZA ZA982808A patent/ZA982808B/xx unknown
-
2000
- 2000-07-06 HK HK00104146A patent/HK1024872A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1998043648A1 (en) | 1998-10-08 |
CA2285434A1 (en) | 1998-10-08 |
HK1024872A1 (en) | 2000-10-27 |
EP0971714A1 (en) | 2000-01-19 |
DE69808607D1 (de) | 2002-11-14 |
EP0971714B1 (en) | 2002-10-09 |
AU725697B2 (en) | 2000-10-19 |
ES2185154T3 (es) | 2003-04-16 |
BR9807920A (pt) | 2000-02-22 |
DE69808607T2 (de) | 2003-06-26 |
JP2002514208A (ja) | 2002-05-14 |
AU6590498A (en) | 1998-10-22 |
PT971714E (pt) | 2002-12-31 |
ZA982808B (en) | 1999-04-06 |
ATE225660T1 (de) | 2002-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
DK0932402T3 (da) | Metode til anvendelse af cyclooxygenase-2-inhibitorer ved behandling og forebyggelse af neoplasi | |
MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
TR200200205T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi | |
NO942064L (no) | yminhibitorer | |
MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
DK0981341T3 (da) | Anvendelse af betulinsyrederivater til behandling og forebyggelse af melanom | |
DK0824588T3 (da) | Inhibitor af IL-6 aktivitet | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
DK0927555T3 (da) | Anvendelse af cyclooxygenase-2-hæmmere til behandling og forebyggelse af tumorer, tumorrelaterede forstyrrelser og kakesi | |
AP2001002205A0 (en) | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase. | |
WO1999005096A3 (en) | Urokinase inhibitors | |
SE9602263D0 (sv) | New amino acid derivatives | |
DK1169337T3 (da) | Steroidnitrater til behandlingen af oxidativ beskadigelse og endothel dysfunktion | |
WO1998036730A3 (de) | Zubereitungen für die behandlung von rosacea | |
WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
DK0796618T3 (da) | Behandling og profylakse af pankreatitis | |
DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
DK0971714T3 (da) | Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens | |
DK0674521T3 (da) | Fremgangsmåde til behandling af kronisk prostatitis med 17beta-N-tertbutylcarbamoyl-4-aza-5a-andost-1-en-3-on | |
NO943765L (no) | Aryloksybenzen-herbicidmidler | |
PT1276722E (pt) | Inibidores de naftamidina-uroquinase |